<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Calcium Channel Blockers</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
    <md:title>Calcium Channel Blockers</md:title>
    <md:content-id>m00291</md:content-id>
    <md:uuid>b1599bf7-a452-4513-92a3-316de5c48411</md:uuid>
  </metadata>
  <content>
    <section class="learning-objectives" id="sect-00001">
      <title>Learning Outcomes</title>
      <para id="para-00001">By the end of this section, you should be able to:</para>
      <list id="list-00001">
      <item>Identify the characteristics of the calcium channel blocker drugs used to treat hypertension and angina.</item>
      <item>Explain the indications, actions, adverse reactions, and interactions of the calcium channel blocker drugs used to treat hypertension and angina.</item>
      <item>Describe nursing implications of calcium channel blocker drugs used to treat hypertension and angina.</item>
      <item>Explain the client education related to calcium channel blocker drugs used to treat hypertension and angina.</item>
      </list>
      </section>
      <section id="sect-00002">
      <title>Introduction and Use</title>
      <para id="para-00002"><term id="term-00001">Calcium channel blockers</term> are a classification of drug that blocks calcium from entering cells by binding to long-acting voltage-gated calcium channels in the heart, smooth muscle, and pancreas. Calcium causes vasoconstriction. Calcium channel blockers inhibit calcium and allow for vasodilation, thereby causing the heart rate to slow and blood pressure to lower. Calcium channel blockers are commonly used to treat hypertension, angina, and arrhythmias.</para>
      <para id="para-00003">Calcium channel blockers are classified as dihydropyridines or nondihydropyridines. Dihydropyridines are peripheral vasodilators that lower blood pressure and heart rate; they are used to treat post-intracranial hemorrhage, vasospasm, and migraines. In addition to their action on the peripheral vasculature, nondihydropyridines inhibit the sinoatrial and AV nodes, slowing cardiac conduction and heart rate, and decreasing oxygen demand.</para>
      <para id="para-00004">Calcium channel blockers may be used alone or in combination with other drugs. They are highly protein bound, which increases the volume of distribution within the body. Calcium channel blockers are available in long- and short-acting formulas.</para>
      <note class="special-considerations" id="note-00001">
      <title>Calcium Channel Blockers</title>
      <para id="para-00005">Calcium channel blockers are among the most effective antihypertensive classification of drug for use in non-Hispanic Black adults.</para>
      <para id="para-00006">(Source: Abrahamowicz et al., 2023)</para>
      </note>
      <note class="safety-alert" id="note-00002">
      <title>Calcium Channel Blockers</title>
      <para id="para-00007">Abrupt discontinuation of calcium channel blockers may cause chest pain.</para>
      </note>
      <para id="para-00007a"><link target-id="table-00001" document="m00291"/> lists common calcium channel blockers and typical routes and dosing for adult clients.</para>
      <table class="vertically-tight" id="table-00001">
      <tgroup cols="2">
      <thead>
      <row>
      <entry><span class="blue-text">Drug</span></entry>
      <entry><span class="blue-text">Routes and Dosage Ranges</span></entry>
      </row>
      </thead>
      <tbody>
      <row>
      <entry><term class="no-emphasis" id="term-00002">Amlodipine</term><newline/>(<term class="no-emphasis" id="term-00003">Norvasc</term>)</entry>
      <entry>5–10 mg daily orally</entry>
      </row>
      <row>
      <entry><term class="no-emphasis" id="term-00004">Diltiazem</term><newline/>(<term class="no-emphasis" id="term-00005">Cardizem</term>)</entry>
      <entry><emphasis effect="italics">Initial dosage:</emphasis> 30 mg orally four times daily, before meals and at bedtime. Increase dosage gradually (given in divided doses three or four times daily) at one- to two-day intervals until optimum response is obtained.<newline/><emphasis effect="italics">Average optimum dosage:</emphasis> 180–360 mg daily.</entry>
      </row>
      <row>
      <entry><term class="no-emphasis" id="term-00006">Nicardipine</term><newline/>(<term class="no-emphasis" id="term-00007">Cardene</term>)</entry>
      <entry><emphasis effect="italics">Sustained release:</emphasis> 30–60 mg daily; maximum dose 120 mg daily<newline/><emphasis effect="italics">Intravenous infusion:</emphasis> 5–15 mg hourly.</entry>
      </row>
      <row>
      <entry><term class="no-emphasis" id="term-00008">Nifedipine</term><newline/>(<term class="no-emphasis" id="term-00009">Procardia</term>)</entry>
      <entry><emphasis effect="italics">Immediate release:</emphasis> Starting dose 10 mg orally three times daily. The usual effective dose range is 10–20 mg three times daily. Doses above 120 mg daily are rarely necessary. More than 180 mg daily is not recommended.<newline/><emphasis effect="italics">Sustained release:</emphasis> 30–60 mg daily orally; maximum dose 120 mg daily.</entry>
      </row>
      <row>
        <entry><term class="no-emphasis" id="term-00010">Verapamil</term><newline/>(<term class="no-emphasis" id="term-00011">Calan SR</term>, <term class="no-emphasis" id="term-00011a">Verelan</term>)</entry>
      <entry><emphasis effect="italics">Immediate release:</emphasis> 40–120 mg three times daily<newline/><emphasis effect="italics">Sustained release:</emphasis> 180–240 mg daily<newline/><emphasis effect="italics">Intravenous:</emphasis> Follow manufacturer’s instructions and health care provider’s orders.</entry>
      </row>
      </tbody>
      </tgroup>
      <caption>Drug Emphasis Table: Calcium Channel Blockers (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
      </table>
      </section>
      <section id="sect-00003">
      <title>Adverse Effects and Contraindications</title>
      <para id="para-00009">Adverse effects of calcium channel blockers include dizziness, constipation, palpitations, fatigue, flushing, nausea, rash, headache, and swelling in the legs and feet. Serious side effects include thrombocytopenia, hypotension, and hyperglycemia. Clients with a hypersensitivity to calcium channel blockers or their components should not use this classification of drug. Other contraindications include sick sinus syndrome (except in clients with an artificial pacemaker), severe hypotension, a history of myocardial infarction, or a history of pulmonary congestion.</para>
      <para id="para-00010"><link target-id="table-00002" document="m00291"/> is a drug prototype table for calcium channel blockers featuring amlodipine. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
      <table class="vertically-tight" id="table-00002">
      <tgroup cols="2">
        <colspec colname="col1" colnum="1" colwidth="1*"/>
        <colspec colname="col2" colnum="2" colwidth="1*"/>
      <tbody>
      <row>
      <entry valign="top">
      <emphasis effect="bold"><span class="blue-text">Drug Class</span></emphasis><newline/>
      Calcium channel blocker<newline count="2"/>
      <emphasis effect="bold"><span class="blue-text">Mechanism of Action</span></emphasis><newline/>
      Inhibits the influx of calcium ions into vascular smooth muscle and cardiac<newline/>muscle, thereby decreasing peripheral vascular resistance and<newline/>reducing blood pressure
      </entry>
      <entry valign="top">
      <emphasis effect="bold"><span class="blue-text">Drug Dosage</span></emphasis><newline/>
      5–10 mg daily orally
      </entry>
      </row>
      <row>
      <entry valign="top">
      <emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
      To control hypertension<newline/>
      In the treatment of angina<newline count="2"/>
      <emphasis effect="bold"><span class="blue-text">Therapeutic Effects</span></emphasis><newline/>
      Lowers blood pressure<newline/>
      Increases blood supply and oxygen to the heart
      </entry>
      <entry valign="top">
      <emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
      Simvastatin<newline/>
      Clarithromycin<newline/>
      Ritonavir<newline count="2"/>
      <emphasis effect="bold"><span class="blue-text">Food Interactions</span></emphasis><newline/>
      No significant interactions<newline/>
      </entry>
      </row>
      <row>
      <entry valign="top">
      <emphasis effect="bold"><span class="blue-text">Adverse Effects</span></emphasis><newline/>
      Peripheral edema<newline/>
      Headache<newline/>
      Fatigue<newline/>
      Palpitations<newline/>
      Hypotension<newline/>
      Dizziness<newline/>
      Nausea<newline/>
      Flushing<newline/>
      Pruritus<newline/>
      Skin rash<newline/>
      Muscle cramps<newline/>
      Erectile dysfunction<newline/>
      </entry>
      <entry valign="top">
      <emphasis effect="bold"><span class="blue-text">Contraindications</span></emphasis><newline/>
      Hypersensitivity<newline count="2"/>
      Caution:<newline/>
      Aortic stenosis<newline/>
      Symptomatic hypotension<newline/>
      Angina<newline/>
      Myocardial infarction<newline/>
      Hepatic impairment<newline/>
      Pregnancy<newline/>
      Breastfeeding<newline/>
      </entry>
      </row>
      </tbody>
      </tgroup>
      <caption>Drug Prototype Table: Amlodipine (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
      </table>
      </section>
      <section id="sect-00004">
      <title>Nursing Implications</title>
      <para id="para-00011">The nurse should do the following for clients who are taking calcium channel blockers:</para>
      <list id="list-00002">
      <item>Monitor the client for interactions because many medications and herbal supplements, such as St. John’s wort, interact with calcium channel blockers. Grapefruit juice also can affect the action of certain calcium channel blockers.</item>
      <item>Assess and monitor the client for adverse effects and contraindications.</item>
      <item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
      </list>
      <note class="client-teaching" id="note-00003">
<para id="para-00011a"><emphasis effect="bold">The client taking a calcium channel blocker should:</emphasis></para>
	 <list list-type="bulleted" id="list-00003">
      <item>Report side effects such as severe headaches, dizziness, lightheadedness, flushing, nausea, and leg swelling to their health care provider.</item>
      <item>Take this medication with food to avoid GI upset, nausea, and vomiting.</item>
      </list>
      </note>
      <note class="black-box" id="note-00004">
      <para id="para-00013a"><emphasis effect="bold">Calcium Channel Blockers</emphasis></para>
      <para id="para-00013">Immediate release nifedipine, a potent calcium blocker, may increase the risk of myocardial infarction, stroke, and arrhythmias.</para>
      </note>
      <note class="unfolding-casestudy" id="note-00006">
        <title>Part B</title>
        <para id="para-00008">Read the following clinical scenario to answer the questions that follow. This case study is a follow-up to Case Study Part A.</para>
        <para id="para-00037">Ms. Tran follows up with her health care provider one week later to get the results of her diagnostic studies. The health care provider diagnoses her with hypertension stage 2 and starts her on enalapril, an ACE inhibitor. The nurse then teaches Ms. Tran about this new drug.</para>
        <exercise id="exer-00003"><problem id="prob-00003"><para id="para-00038"><link class="os-embed" url="#exercise/PHAR_Ch18_Sec5_UCSQ1"/></para></problem></exercise>
        <exercise id="exer-00004"><problem id="prob-00004"><para id="para-00039"><link class="os-embed" url="#exercise/PHAR_Ch18_Sec5_UCSQ2"/></para></problem></exercise>
        </note>
      </section>
      </content>
      <glossary>
      <definition id="def-00001"><term>calcium channel blocker</term> <meaning>a classification of drug that blocks calcium from entering cells by binding to long-acting voltage-gated calcium channels in the heart, smooth muscle, and pancreas</meaning></definition>
      </glossary>
  
</document>